Zobrazeno 1 - 10
of 70
pro vyhledávání: '"SATORU NANNO"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Key Clinical Message When chronic lymphocytic leukemia progressed to Richter syndrome, the coexistence of small and large lymphocytes was observed as a bone marrow finding. We consider this finding to be a clue for the progression of chronic lymphocy
Externí odkaz:
https://doaj.org/article/e6a660d83c3b4de1861ae1d618243e89
Autor:
Masahiro Manabe, Naoyuki Inano, Yuuji Hagiwara, Nobuhiro Sogabe, Satoru Nanno, Takeshi Mazaki, Ki‐Ryang Koh
Publikováno v:
Cancer Reports, Vol 7, Iss 3, Pp n/a-n/a (2024)
Abstract Background Cancer‐related thrombotic microangiopathy (CR‐TMA) is a rare type of Coombs‐negative hemolytic anemia, which is caused by malignancy and has a poor prognosis. Case A 76‐year‐old female was referred to our hospital due to
Externí odkaz:
https://doaj.org/article/7c75b65537214f65807493742d96d4a7
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 528-529 (2023)
Externí odkaz:
https://doaj.org/article/2f4895ce7acc47b4b34d166a48ebf51b
Publikováno v:
Cancer Reports, Vol 5, Iss 10, Pp n/a-n/a (2022)
Abstract Background and Case We herein present a case of the co‐occurrence of JAK2‐mutated essential thrombocythemia (ET) with chronic lymphocytic leukemia (CLL) harboring the recurrent and rare whole‐arm translocation, der(8;17)(q10;q10). The
Externí odkaz:
https://doaj.org/article/39da852a9df346168bdba3e04057dc17
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 256-258 (2022)
Externí odkaz:
https://doaj.org/article/417038e5879548c2a92050c44f2f6560
High‐grade B‐cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib
Autor:
Teruhito Takakuwa, Ryota Sakai, Shiro Koh, Hiroshi Okamura, Satoru Nanno, Yasuhiro Nakashima, Takahiko Nakane, Hideo Koh, Masayuki Hino, Hirohisa Nakamae
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1344-1349 (2021)
Abstract Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed clinical course of patie
Externí odkaz:
https://doaj.org/article/38340fb4f75c470bb3d7258188f184e7
Autor:
Naonori Harada, Wataru Shibata, Hideo Koh, Emi Takashita, Seiichiro Fujisaki, Hiroshi Okamura, Satoru Nanno, Koichi Yamada, Hirohisa Nakamae, Masayuki Hino, Hiroshi Kakeya
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-5 (2020)
Abstract Background Extended use of oseltamivir in an immunocompromised host could reportedly induce neuraminidase gene mutation possibly leading to oseltamivir-resistant influenza A/H3N2 virus. To our knowledge, no report is available on the clinica
Externí odkaz:
https://doaj.org/article/64ff82206ad94f1a82f4178f199f41be
Autor:
Soichiro Nakako, Teruhito Takakuwa, Hirona Ichimura, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae
Publikováno v:
Clinical Case Reports, Vol 9, Iss 6, Pp n/a-n/a (2021)
Abstract A 55‐year‐old man was diagnosed with therapy‐related chronic myelomonocytic leukemia (t‐CMML) after exposure to tegafur/gimeracil/oteracil. Although he was refractory to hydroxyurea and low‐dose cytarabine, combination therapy with
Externí odkaz:
https://doaj.org/article/803b8841e54f4f44ae2040c28a784497
Autor:
Yosuke Nakaya, Yasuhiro Nakashima, Naonori Harada, Koichi Yamada, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Hideo Koh, Yu Nakagama, Yasutoshi Kido, Takayuki Kanno, Tadaki Suzuki, Hirohisa Nakamae, Hiroshi Kakeya, Masayuki Hino
Publikováno v:
Journal of Infection and Chemotherapy. 29:223-227
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4595c41c1fa67bc2b14ab214df84618e
https://doi.org/10.1016/j.jiac.2022.10.020
https://doi.org/10.1016/j.jiac.2022.10.020
Autor:
MASAHIRO MANABE, YOKO TANI, NAOYUKI INANO, YUUJI HAGIWARA, NOBUHIRO SOGABE, SATORU NANNO, KI-RHANG KOH
Publikováno v:
Medicine International (2754-3242); Jan/Feb2024, Vol. 4 Issue 1, p1-4, 4p